HEADER OXIDOREDUCTASE 20-OCT-14 4D3A TITLE STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME TITLE 2 DOMAIN IN COMPLEX WITH 3-(3-FLUOROPHENYL)-N-2-(2-(5-METHYL- TITLE 3 1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL)ETHYLPROPAN-1-AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NITRIC OXIDE SYNTHASE, ENDOTHELIAL; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HEME DOMAIN, UNP RESIDUES 40-482; COMPND 5 SYNONYM: CONSTITUTIVE NOS, CNOS, EC-NOS, ENDOTHELIAL NOS, ENOS, NOS COMPND 6 TYPE III, NOSIII, ENDOTHELIAL NITRIC OXIDE SYNTHASE; COMPND 7 EC: 1.14.13.39; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PCWORI KEYWDS OXIDOREDUCTASE, NITRIC OXIDE SYNTHASE, INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.CHREIFI,H.LI,T.L.POULOS REVDAT 2 04-MAR-15 4D3A 1 JRNL REVDAT 1 24-DEC-14 4D3A 0 JRNL AUTH P.MUKHERJEE,H.LI,I.SEVRIOUKOVA,G.CHREIFI,P.MARTASEK, JRNL AUTH 2 L.J.ROMAN,T.L.POULOS,R.B.SILVERMAN JRNL TITL NOVEL 2,4-DISUBSTITUTED PYRIMIDINES AS POTENT, SELECTIVE, JRNL TITL 2 AND CELL-PERMEABLE INHIBITORS OF NEURONAL NITRIC OXIDE JRNL TITL 3 SYNTHASE. JRNL REF J.MED.CHEM. V. 58 1067 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25489882 JRNL DOI 10.1021/JM501719E REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.252 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.988 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.29 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.53 REMARK 3 NUMBER OF REFLECTIONS : 86036 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.1645 REMARK 3 R VALUE (WORKING SET) : 0.1621 REMARK 3 FREE R VALUE : 0.2104 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 4273 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.9938 - 6.9832 0.99 2717 156 0.1445 0.1815 REMARK 3 2 6.9832 - 5.5479 1.00 2716 162 0.1510 0.1721 REMARK 3 3 5.5479 - 4.8481 1.00 2775 131 0.1271 0.2064 REMARK 3 4 4.8481 - 4.4055 0.99 2764 125 0.1086 0.1335 REMARK 3 5 4.4055 - 4.0901 0.99 2724 154 0.1129 0.1816 REMARK 3 6 4.0901 - 3.8492 1.00 2797 130 0.1245 0.1656 REMARK 3 7 3.8492 - 3.6565 0.99 2706 158 0.1270 0.1782 REMARK 3 8 3.6565 - 3.4975 0.99 2751 142 0.1307 0.1885 REMARK 3 9 3.4975 - 3.3629 0.99 2716 137 0.1383 0.1802 REMARK 3 10 3.3629 - 3.2469 0.99 2756 142 0.1562 0.1960 REMARK 3 11 3.2469 - 3.1454 0.99 2739 153 0.1642 0.2672 REMARK 3 12 3.1454 - 3.0556 0.99 2748 127 0.1615 0.2124 REMARK 3 13 3.0556 - 2.9752 0.98 2729 161 0.1670 0.2061 REMARK 3 14 2.9752 - 2.9026 1.00 2718 149 0.1726 0.2265 REMARK 3 15 2.9026 - 2.8366 0.97 2726 129 0.1819 0.2225 REMARK 3 16 2.8366 - 2.7763 1.00 2751 103 0.1880 0.2496 REMARK 3 17 2.7763 - 2.7208 0.98 2731 137 0.2019 0.2687 REMARK 3 18 2.7208 - 2.6694 0.99 2745 140 0.2040 0.2604 REMARK 3 19 2.6694 - 2.6218 1.00 2727 125 0.2197 0.2474 REMARK 3 20 2.6218 - 2.5773 0.96 2699 163 0.2286 0.2542 REMARK 3 21 2.5773 - 2.5358 1.00 2743 168 0.2409 0.3250 REMARK 3 22 2.5358 - 2.4968 0.99 2665 145 0.2614 0.2875 REMARK 3 23 2.4968 - 2.4600 0.96 2643 158 0.2585 0.2890 REMARK 3 24 2.4600 - 2.4254 0.99 2774 157 0.2716 0.3257 REMARK 3 25 2.4254 - 2.3926 0.99 2721 142 0.2759 0.3335 REMARK 3 26 2.3926 - 2.3616 0.96 2649 142 0.2963 0.3456 REMARK 3 27 2.3616 - 2.3320 0.99 2725 160 0.3162 0.3590 REMARK 3 28 2.3320 - 2.3039 1.00 2690 133 0.3266 0.3755 REMARK 3 29 2.3039 - 2.2772 0.96 2750 112 0.3435 0.3829 REMARK 3 30 2.2772 - 2.2516 0.95 2668 132 0.3265 0.3673 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.34 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.45 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.25 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 6864 REMARK 3 ANGLE : 1.101 9371 REMARK 3 CHIRALITY : 0.069 973 REMARK 3 PLANARITY : 0.005 1206 REMARK 3 DIHEDRAL : 16.269 2489 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESID 67:482) REMARK 3 ORIGIN FOR THE GROUP (A): 11.2078 10.4472 31.7857 REMARK 3 T TENSOR REMARK 3 T11: 0.1859 T22: 0.1424 REMARK 3 T33: 0.1720 T12: -0.0424 REMARK 3 T13: 0.0120 T23: -0.0038 REMARK 3 L TENSOR REMARK 3 L11: 0.9866 L22: 1.0984 REMARK 3 L33: 1.4225 L12: -0.4475 REMARK 3 L13: -0.5777 L23: 0.4828 REMARK 3 S TENSOR REMARK 3 S11: 0.0001 S12: -0.0412 S13: -0.0003 REMARK 3 S21: -0.1238 S22: 0.0879 S23: -0.1337 REMARK 3 S31: -0.0522 S32: 0.0795 S33: -0.0531 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN B AND RESID 69:482) REMARK 3 ORIGIN FOR THE GROUP (A): 2.5778 5.8704 67.4429 REMARK 3 T TENSOR REMARK 3 T11: 0.1563 T22: 0.2045 REMARK 3 T33: 0.1959 T12: -0.0309 REMARK 3 T13: -0.0124 T23: 0.0116 REMARK 3 L TENSOR REMARK 3 L11: 0.7566 L22: 1.0274 REMARK 3 L33: 2.2830 L12: -0.3861 REMARK 3 L13: 0.2898 L23: -0.9736 REMARK 3 S TENSOR REMARK 3 S11: 0.0540 S12: -0.0675 S13: -0.0462 REMARK 3 S21: 0.0474 S22: 0.0419 S23: 0.0067 REMARK 3 S31: -0.0085 S32: -0.0149 S33: -0.0673 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 110 TO 120 IN BOTH CHAIN A REMARK 3 AND CHAIN B ARE DISORDERED. REMARK 4 REMARK 4 4D3A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-OCT-14. REMARK 100 THE PDBE ID CODE IS EBI-62022. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUL-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.127 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD (MAR325) REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45581 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.25 REMARK 200 RESOLUTION RANGE LOW (A) : 50.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.1 REMARK 200 R MERGE (I) : 0.08 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.20 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.2 REMARK 200 R MERGE FOR SHELL (I) : 1.34 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.10 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: RPIM 0.742 CC ONE HALF 0.435 REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.7 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.5 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-22% PEG3350, 0.1 M REMARK 280 CACODYLATE, 150-200 MM MG ACETATE, 5 MM TCEP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.81150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 77.97600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.93850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 77.97600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.81150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.93850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -134.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 40 REMARK 465 ALA A 41 REMARK 465 PRO A 42 REMARK 465 ALA A 43 REMARK 465 PRO A 44 REMARK 465 ALA A 45 REMARK 465 THR A 46 REMARK 465 PRO A 47 REMARK 465 HIS A 48 REMARK 465 ALA A 49 REMARK 465 PRO A 50 REMARK 465 ASP A 51 REMARK 465 HIS A 52 REMARK 465 SER A 53 REMARK 465 PRO A 54 REMARK 465 ALA A 55 REMARK 465 PRO A 56 REMARK 465 ASN A 57 REMARK 465 SER A 58 REMARK 465 PRO A 59 REMARK 465 THR A 60 REMARK 465 LEU A 61 REMARK 465 THR A 62 REMARK 465 ARG A 63 REMARK 465 PRO A 64 REMARK 465 PRO A 65 REMARK 465 GLU A 66 REMARK 465 LYS A 110 REMARK 465 LEU A 111 REMARK 465 GLN A 112 REMARK 465 THR A 113 REMARK 465 ARG A 114 REMARK 465 PRO A 115 REMARK 465 SER A 116 REMARK 465 PRO A 117 REMARK 465 GLY A 118 REMARK 465 PRO A 119 REMARK 465 PRO A 120 REMARK 465 ARG B 40 REMARK 465 ALA B 41 REMARK 465 PRO B 42 REMARK 465 ALA B 43 REMARK 465 PRO B 44 REMARK 465 ALA B 45 REMARK 465 THR B 46 REMARK 465 PRO B 47 REMARK 465 HIS B 48 REMARK 465 ALA B 49 REMARK 465 PRO B 50 REMARK 465 ASP B 51 REMARK 465 HIS B 52 REMARK 465 SER B 53 REMARK 465 PRO B 54 REMARK 465 ALA B 55 REMARK 465 PRO B 56 REMARK 465 ASN B 57 REMARK 465 SER B 58 REMARK 465 PRO B 59 REMARK 465 THR B 60 REMARK 465 LEU B 61 REMARK 465 THR B 62 REMARK 465 ARG B 63 REMARK 465 PRO B 64 REMARK 465 PRO B 65 REMARK 465 GLU B 66 REMARK 465 GLY B 67 REMARK 465 PRO B 68 REMARK 465 LEU B 111 REMARK 465 GLN B 112 REMARK 465 THR B 113 REMARK 465 ARG B 114 REMARK 465 PRO B 115 REMARK 465 SER B 116 REMARK 465 PRO B 117 REMARK 465 GLY B 118 REMARK 465 PRO B 119 REMARK 465 PRO B 120 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2A GLU A 363 O HOH A 2169 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 285 43.42 -154.53 REMARK 500 ALA A 353 67.71 -158.01 REMARK 500 ARG A 374 -136.03 -116.02 REMARK 500 ARG A 440 -5.86 -141.65 REMARK 500 ASP B 202 39.25 -95.73 REMARK 500 ASP B 260 38.72 -82.65 REMARK 500 ASN B 285 34.55 -147.55 REMARK 500 ALA B 353 65.92 -157.60 REMARK 500 THR B 366 -63.37 -95.92 REMARK 500 ARG B 374 -134.04 -114.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2094 DISTANCE = 5.17 ANGSTROMS REMARK 525 HOH B2036 DISTANCE = 6.45 ANGSTROMS REMARK 525 HOH B2073 DISTANCE = 5.18 ANGSTROMS REMARK 525 HOH B2165 DISTANCE = 5.38 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 500 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HEM A 500 NC REMARK 620 2 CYS A 186 SG 92.0 REMARK 620 3 HEM A 500 ND 91.4 97.9 REMARK 620 4 HEM A 500 NB 89.1 88.2 173.9 REMARK 620 5 7F5 A 800 N01 84.5 171.1 90.4 83.6 REMARK 620 6 HEM A 500 NA 177.3 90.0 90.0 89.2 93.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 500 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HEM B 500 NB REMARK 620 2 HEM B 500 NA 87.9 REMARK 620 3 7F5 B 800 N01 83.7 86.8 REMARK 620 4 HEM B 500 NC 87.8 173.8 88.2 REMARK 620 5 HEM B 500 ND 173.2 91.0 89.5 92.8 REMARK 620 6 CYS B 186 SG 90.7 98.5 172.2 86.0 96.0 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 900 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 101 SG REMARK 620 2 CYS B 96 SG 112.8 REMARK 620 3 CYS A 101 SG 106.0 105.1 REMARK 620 4 CYS A 96 SG 104.8 120.7 106.5 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7F5 A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 860 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 861 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 880 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 900 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B B 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7F5 B 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 860 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 861 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 880 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4D2Y RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-(S,R)-2-(3-FLUOROBENZYL) REMARK 900 CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D2Z RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-(R,S)-2-(3-FLUOROBENZYL) REMARK 900 CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D30 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(PYRIDIN-3-YL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4D31 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(3-CYANOBENZYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D32 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 3-(3-FLUOROPHENYL)-N-2-(2-( REMARK 900 5-METHYL-1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL)ETHYLPROPAN REMARK 900 -1-AMINE REMARK 900 RELATED ID: 4D33 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH (N1-(2-(1H-IMIDAZOL-1- REMARK 900 YL)PYRIMIDIN-4-YL)-N2-(3-FLUOROPHENETHYL)ETHANE-1,2 REMARK 900 -DIAMINE REMARK 900 RELATED ID: 4D34 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL REMARK 900 )PYRIMIDIN-4-YL)-N-(3-FLUOROPHENETHYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D35 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 REMARK 900 -YL)PYRIMIDIN-4-YL)ETHYL-3-(3-FLUOROPHENYL)PROPAN-1 REMARK 900 -AMINE REMARK 900 RELATED ID: 4D36 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 REMARK 900 -YL)PYRIMIDIN-4-YL)ETHYL-3-(3-CHLOROPHENYL)PROPAN-1 REMARK 900 -AMINE REMARK 900 RELATED ID: 4D37 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITHN-{[(1R,2R)-2-(3- REMARK 900 FLUOROPHENYL)CYCLOPROPYL]METHYL}-2-[2-(1H-IMIDAZOL-1- REMARK 900 YL)PYRIMIDIN-4-YL]ETHANAMINE REMARK 900 RELATED ID: 4D38 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 REMARK 900 -YL)PYRIMIDIN-4-YL)ETHYL-(S,R)-2-(3-FLUOROBENZYL) REMARK 900 CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D39 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(3-CYANOBENZYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D3B RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N1-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N2-(3-FLUOROPHENETHYL)ETHANE-1,2- REMARK 900 DIAMINE REMARK 900 RELATED ID: 4V3U RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN NNOS R354A G357D MUTANT HEME DOMAIN REMARK 900 IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(PYRIDIN-3-YL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4V3V RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-(2-(1H-IMIDAZOL-1-YL)-4- REMARK 900 PYRIMIDYLMETHYL)-3-(3-FLUOROPHENYL)PROPAN-1-AMINE REMARK 900 RELATED ID: 4V3W RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(3-FLUOROPHENETHYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4V3X RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(3-FLUOROPHENYL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4V3Y RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(3-CHLOROPHENYL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4V3Z RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(2-(3-FLUOROPHENYL)CYCLOPROPYLMETHYL) REMARK 900 ETHAN-1-AMINE REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUE 100 IS FOUND AS AN ARG IN STRUCTURE BUT IS A CYS REMARK 999 IN DATABASE DBREF 4D3A A 40 482 UNP P29473 NOS3_BOVIN 40 482 DBREF 4D3A B 40 482 UNP P29473 NOS3_BOVIN 40 482 SEQADV 4D3A ARG A 100 UNP P29473 CYS 100 CONFLICT SEQADV 4D3A ARG B 100 UNP P29473 CYS 100 CONFLICT SEQRES 1 A 443 ARG ALA PRO ALA PRO ALA THR PRO HIS ALA PRO ASP HIS SEQRES 2 A 443 SER PRO ALA PRO ASN SER PRO THR LEU THR ARG PRO PRO SEQRES 3 A 443 GLU GLY PRO LYS PHE PRO ARG VAL LYS ASN TRP GLU LEU SEQRES 4 A 443 GLY SER ILE THR TYR ASP THR LEU CYS ALA GLN SER GLN SEQRES 5 A 443 GLN ASP GLY PRO CYS THR PRO ARG ARG CYS LEU GLY SER SEQRES 6 A 443 LEU VAL LEU PRO ARG LYS LEU GLN THR ARG PRO SER PRO SEQRES 7 A 443 GLY PRO PRO PRO ALA GLU GLN LEU LEU SER GLN ALA ARG SEQRES 8 A 443 ASP PHE ILE ASN GLN TYR TYR SER SER ILE LYS ARG SER SEQRES 9 A 443 GLY SER GLN ALA HIS GLU GLU ARG LEU GLN GLU VAL GLU SEQRES 10 A 443 ALA GLU VAL ALA SER THR GLY THR TYR HIS LEU ARG GLU SEQRES 11 A 443 SER GLU LEU VAL PHE GLY ALA LYS GLN ALA TRP ARG ASN SEQRES 12 A 443 ALA PRO ARG CYS VAL GLY ARG ILE GLN TRP GLY LYS LEU SEQRES 13 A 443 GLN VAL PHE ASP ALA ARG ASP CYS SER SER ALA GLN GLU SEQRES 14 A 443 MET PHE THR TYR ILE CYS ASN HIS ILE LYS TYR ALA THR SEQRES 15 A 443 ASN ARG GLY ASN LEU ARG SER ALA ILE THR VAL PHE PRO SEQRES 16 A 443 GLN ARG ALA PRO GLY ARG GLY ASP PHE ARG ILE TRP ASN SEQRES 17 A 443 SER GLN LEU VAL ARG TYR ALA GLY TYR ARG GLN GLN ASP SEQRES 18 A 443 GLY SER VAL ARG GLY ASP PRO ALA ASN VAL GLU ILE THR SEQRES 19 A 443 GLU LEU CYS ILE GLN HIS GLY TRP THR PRO GLY ASN GLY SEQRES 20 A 443 ARG PHE ASP VAL LEU PRO LEU LEU LEU GLN ALA PRO ASP SEQRES 21 A 443 GLU ALA PRO GLU LEU PHE VAL LEU PRO PRO GLU LEU VAL SEQRES 22 A 443 LEU GLU VAL PRO LEU GLU HIS PRO THR LEU GLU TRP PHE SEQRES 23 A 443 ALA ALA LEU GLY LEU ARG TRP TYR ALA LEU PRO ALA VAL SEQRES 24 A 443 SER ASN MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER SEQRES 25 A 443 ALA ALA PRO PHE SER GLY TRP TYR MET SER THR GLU ILE SEQRES 26 A 443 GLY THR ARG ASN LEU CYS ASP PRO HIS ARG TYR ASN ILE SEQRES 27 A 443 LEU GLU ASP VAL ALA VAL CAS MET ASP LEU ASP THR ARG SEQRES 28 A 443 THR THR SER SER LEU TRP LYS ASP LYS ALA ALA VAL GLU SEQRES 29 A 443 ILE ASN LEU ALA VAL LEU HIS SER PHE GLN LEU ALA LYS SEQRES 30 A 443 VAL THR ILE VAL ASP HIS HIS ALA ALA THR VAL SER PHE SEQRES 31 A 443 MET LYS HIS LEU ASP ASN GLU GLN LYS ALA ARG GLY GLY SEQRES 32 A 443 CYS PRO ALA ASP TRP ALA TRP ILE VAL PRO PRO ILE SER SEQRES 33 A 443 GLY SER LEU THR PRO VAL PHE HIS GLN GLU MET VAL ASN SEQRES 34 A 443 TYR ILE LEU SER PRO ALA PHE ARG TYR GLN PRO ASP PRO SEQRES 35 A 443 TRP SEQRES 1 B 443 ARG ALA PRO ALA PRO ALA THR PRO HIS ALA PRO ASP HIS SEQRES 2 B 443 SER PRO ALA PRO ASN SER PRO THR LEU THR ARG PRO PRO SEQRES 3 B 443 GLU GLY PRO LYS PHE PRO ARG VAL LYS ASN TRP GLU LEU SEQRES 4 B 443 GLY SER ILE THR TYR ASP THR LEU CYS ALA GLN SER GLN SEQRES 5 B 443 GLN ASP GLY PRO CYS THR PRO ARG ARG CYS LEU GLY SER SEQRES 6 B 443 LEU VAL LEU PRO ARG LYS LEU GLN THR ARG PRO SER PRO SEQRES 7 B 443 GLY PRO PRO PRO ALA GLU GLN LEU LEU SER GLN ALA ARG SEQRES 8 B 443 ASP PHE ILE ASN GLN TYR TYR SER SER ILE LYS ARG SER SEQRES 9 B 443 GLY SER GLN ALA HIS GLU GLU ARG LEU GLN GLU VAL GLU SEQRES 10 B 443 ALA GLU VAL ALA SER THR GLY THR TYR HIS LEU ARG GLU SEQRES 11 B 443 SER GLU LEU VAL PHE GLY ALA LYS GLN ALA TRP ARG ASN SEQRES 12 B 443 ALA PRO ARG CYS VAL GLY ARG ILE GLN TRP GLY LYS LEU SEQRES 13 B 443 GLN VAL PHE ASP ALA ARG ASP CYS SER SER ALA GLN GLU SEQRES 14 B 443 MET PHE THR TYR ILE CYS ASN HIS ILE LYS TYR ALA THR SEQRES 15 B 443 ASN ARG GLY ASN LEU ARG SER ALA ILE THR VAL PHE PRO SEQRES 16 B 443 GLN ARG ALA PRO GLY ARG GLY ASP PHE ARG ILE TRP ASN SEQRES 17 B 443 SER GLN LEU VAL ARG TYR ALA GLY TYR ARG GLN GLN ASP SEQRES 18 B 443 GLY SER VAL ARG GLY ASP PRO ALA ASN VAL GLU ILE THR SEQRES 19 B 443 GLU LEU CYS ILE GLN HIS GLY TRP THR PRO GLY ASN GLY SEQRES 20 B 443 ARG PHE ASP VAL LEU PRO LEU LEU LEU GLN ALA PRO ASP SEQRES 21 B 443 GLU ALA PRO GLU LEU PHE VAL LEU PRO PRO GLU LEU VAL SEQRES 22 B 443 LEU GLU VAL PRO LEU GLU HIS PRO THR LEU GLU TRP PHE SEQRES 23 B 443 ALA ALA LEU GLY LEU ARG TRP TYR ALA LEU PRO ALA VAL SEQRES 24 B 443 SER ASN MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER SEQRES 25 B 443 ALA ALA PRO PHE SER GLY TRP TYR MET SER THR GLU ILE SEQRES 26 B 443 GLY THR ARG ASN LEU CYS ASP PRO HIS ARG TYR ASN ILE SEQRES 27 B 443 LEU GLU ASP VAL ALA VAL CAS MET ASP LEU ASP THR ARG SEQRES 28 B 443 THR THR SER SER LEU TRP LYS ASP LYS ALA ALA VAL GLU SEQRES 29 B 443 ILE ASN LEU ALA VAL LEU HIS SER PHE GLN LEU ALA LYS SEQRES 30 B 443 VAL THR ILE VAL ASP HIS HIS ALA ALA THR VAL SER PHE SEQRES 31 B 443 MET LYS HIS LEU ASP ASN GLU GLN LYS ALA ARG GLY GLY SEQRES 32 B 443 CYS PRO ALA ASP TRP ALA TRP ILE VAL PRO PRO ILE SER SEQRES 33 B 443 GLY SER LEU THR PRO VAL PHE HIS GLN GLU MET VAL ASN SEQRES 34 B 443 TYR ILE LEU SER PRO ALA PHE ARG TYR GLN PRO ASP PRO SEQRES 35 B 443 TRP MODRES 4D3A CAS A 384 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4D3A CAS B 384 CYS S-(DIMETHYLARSENIC)CYSTEINE HET CAS A 384 9 HET HEM A 500 43 HET H4B A 600 17 HET 7F5 A 800 25 HET ACT A 860 4 HET ACT A 861 4 HET GOL A 880 6 HET ZN A 900 1 HET CAS B 384 9 HET HEM B 500 43 HET H4B B 600 17 HET 7F5 B 800 25 HET ACT B 860 4 HET ACT B 861 4 HET GOL B 880 6 HETNAM H4B 5,6,7,8-TETRAHYDROBIOPTERIN HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM ZN ZINC ION HETNAM GOL GLYCEROL HETNAM 7F5 3-(3-FLUOROPHENYL)-N-{2-[2-(5-METHYL-1H- HETNAM 2 7F5 IMIDAZOL-1-YL)PYRIMIDIN-4-YL]ETHYL}PROPAN-1- HETNAM 3 7F5 AMINE HETNAM ACT ACETATE ION HETNAM CAS S-(DIMETHYLARSENIC)CYSTEINE HETSYN HEM HEME HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 H4B 2(C9 H15 N5 O3) FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 ZN ZN 2+ FORMUL 5 GOL 2(C3 H8 O3) FORMUL 6 7F5 2(C19 H22 F N5) FORMUL 7 ACT 4(C2 H3 O2 1-) FORMUL 8 CAS 2(C5 H12 AS N O2 S) FORMUL 9 HOH *390(H2 O) HELIX 1 1 THR A 85 SER A 90 5 6 HELIX 2 2 PRO A 121 ILE A 140 1 20 HELIX 3 3 SER A 145 GLY A 163 1 19 HELIX 4 4 ARG A 168 ASN A 182 1 15 HELIX 5 5 GLY A 188 LEU A 195 5 8 HELIX 6 6 SER A 205 ASN A 222 1 18 HELIX 7 7 ARG A 223 ASN A 225 5 3 HELIX 8 8 ASN A 269 HIS A 279 1 11 HELIX 9 9 PRO A 308 VAL A 312 5 5 HELIX 10 10 LEU A 322 GLY A 329 5 8 HELIX 11 11 MET A 360 THR A 366 1 7 HELIX 12 12 THR A 366 ASP A 371 1 6 HELIX 13 13 ILE A 377 MET A 385 1 9 HELIX 14 14 THR A 391 SER A 394 5 4 HELIX 15 15 LEU A 395 ALA A 415 1 21 HELIX 16 16 ASP A 421 GLY A 441 1 21 HELIX 17 17 ASP A 446 VAL A 451 1 6 HELIX 18 18 SER A 455 THR A 459 5 5 HELIX 19 19 THR A 459 HIS A 463 5 5 HELIX 20 20 THR B 85 SER B 90 5 6 HELIX 21 21 PRO B 121 ILE B 140 1 20 HELIX 22 22 SER B 145 GLY B 163 1 19 HELIX 23 23 ARG B 168 ASN B 182 1 15 HELIX 24 24 GLY B 188 TRP B 192 5 5 HELIX 25 25 SER B 205 ASN B 222 1 18 HELIX 26 26 ARG B 223 ASN B 225 5 3 HELIX 27 27 ASN B 269 HIS B 279 1 11 HELIX 28 28 PRO B 308 VAL B 312 5 5 HELIX 29 29 TRP B 324 GLY B 329 5 6 HELIX 30 30 MET B 360 THR B 366 1 7 HELIX 31 31 THR B 366 ASP B 371 1 6 HELIX 32 32 ILE B 377 MET B 385 1 9 HELIX 33 33 THR B 391 SER B 394 5 4 HELIX 34 34 LEU B 395 ALA B 415 1 21 HELIX 35 35 ASP B 421 GLY B 441 1 21 HELIX 36 36 ASP B 446 VAL B 451 1 6 HELIX 37 37 SER B 455 THR B 459 5 5 HELIX 38 38 THR B 459 HIS B 463 5 5 SHEET 1 AA 2 ARG A 72 LYS A 74 0 SHEET 2 AA 2 ILE A 81 TYR A 83 -1 O THR A 82 N VAL A 73 SHEET 1 AB 4 GLN A 196 ASP A 199 0 SHEET 2 AB 4 ALA A 229 VAL A 232 1 O ILE A 230 N PHE A 198 SHEET 3 AB 4 PHE A 355 SER A 356 -1 O SER A 356 N ALA A 229 SHEET 4 AB 4 ALA A 337 VAL A 338 -1 O VAL A 338 N PHE A 355 SHEET 1 AC 3 ARG A 244 ILE A 245 0 SHEET 2 AC 3 LEU A 293 GLN A 296 -1 O GLN A 296 N ARG A 244 SHEET 3 AC 3 GLU A 303 PHE A 305 -1 O GLU A 303 N LEU A 295 SHEET 1 AD 2 GLY A 255 ARG A 257 0 SHEET 2 AD 2 VAL A 263 GLY A 265 -1 O ARG A 264 N TYR A 256 SHEET 1 AE 2 GLU A 314 PRO A 316 0 SHEET 2 AE 2 ARG A 331 TYR A 333 -1 O TRP A 332 N VAL A 315 SHEET 1 AF 3 LEU A 348 PHE A 350 0 SHEET 2 AF 3 LEU A 342 ILE A 345 -1 O LEU A 343 N PHE A 350 SHEET 3 AF 3 ALA A 474 ARG A 476 -1 O ALA A 474 N GLU A 344 SHEET 1 BA 2 ARG B 72 LYS B 74 0 SHEET 2 BA 2 ILE B 81 TYR B 83 -1 O THR B 82 N VAL B 73 SHEET 1 BB 4 GLN B 196 ASP B 199 0 SHEET 2 BB 4 ALA B 229 VAL B 232 1 O ILE B 230 N PHE B 198 SHEET 3 BB 4 PHE B 355 SER B 356 -1 O SER B 356 N ALA B 229 SHEET 4 BB 4 ALA B 337 VAL B 338 -1 O VAL B 338 N PHE B 355 SHEET 1 BC 3 ARG B 244 ILE B 245 0 SHEET 2 BC 3 LEU B 293 GLN B 296 -1 O GLN B 296 N ARG B 244 SHEET 3 BC 3 GLU B 303 PHE B 305 -1 O GLU B 303 N LEU B 295 SHEET 1 BD 2 GLY B 255 ARG B 257 0 SHEET 2 BD 2 VAL B 263 GLY B 265 -1 O ARG B 264 N TYR B 256 SHEET 1 BE 2 GLU B 314 PRO B 316 0 SHEET 2 BE 2 ARG B 331 TYR B 333 -1 O TRP B 332 N VAL B 315 SHEET 1 BF 3 LEU B 348 PHE B 350 0 SHEET 2 BF 3 LEU B 342 ILE B 345 -1 O LEU B 343 N PHE B 350 SHEET 3 BF 3 ALA B 474 ARG B 476 -1 O ALA B 474 N GLU B 344 LINK SG CYS A 186 FE HEM A 500 1555 1555 2.30 LINK C VAL A 383 N CAS A 384 1555 1555 1.33 LINK C CAS A 384 N MET A 385 1555 1555 1.33 LINK FE HEM A 500 N01 7F5 A 800 1555 1555 2.29 LINK ZN ZN A 900 SG CYS B 101 1555 1555 2.32 LINK ZN ZN A 900 SG CYS B 96 1555 1555 2.37 LINK ZN ZN A 900 SG CYS A 101 1555 1555 2.38 LINK ZN ZN A 900 SG CYS A 96 1555 1555 2.39 LINK SG CYS B 186 FE HEM B 500 1555 1555 2.26 LINK C VAL B 383 N CAS B 384 1555 1555 1.33 LINK C CAS B 384 N MET B 385 1555 1555 1.33 LINK FE HEM B 500 N01 7F5 B 800 1555 1555 2.26 CISPEP 1 SER A 472 PRO A 473 0 1.25 CISPEP 2 SER B 472 PRO B 473 0 -0.35 SITE 1 AC1 16 TRP A 180 ARG A 185 CYS A 186 VAL A 187 SITE 2 AC1 16 SER A 228 PHE A 355 SER A 356 TRP A 358 SITE 3 AC1 16 MET A 360 GLU A 363 TRP A 449 PHE A 475 SITE 4 AC1 16 TYR A 477 H4B A 600 7F5 A 800 HOH A2224 SITE 1 AC2 13 SER A 104 VAL A 106 ARG A 367 ALA A 448 SITE 2 AC2 13 TRP A 449 HEM A 500 GOL A 880 HOH A2172 SITE 3 AC2 13 HOH A2206 TRP B 447 PHE B 462 GLN B 464 SITE 4 AC2 13 GLU B 465 SITE 1 AC3 11 VAL A 106 LEU A 107 GLN A 249 PRO A 336 SITE 2 AC3 11 ALA A 337 VAL A 338 PHE A 355 HEM A 500 SITE 3 AC3 11 ACT A 861 GOL A 880 TRP B 76 SITE 1 AC4 5 GLY A 188 TRP A 358 VAL A 420 SER A 428 SITE 2 AC4 5 HOH A2079 SITE 1 AC5 5 GLN A 249 ARG A 252 TYR A 359 ASN A 368 SITE 2 AC5 5 7F5 A 800 SITE 1 AC6 6 ARG A 367 HIS A 373 H4B A 600 7F5 A 800 SITE 2 AC6 6 HOH A2172 TRP B 76 SITE 1 AC7 4 CYS A 96 CYS A 101 CYS B 96 CYS B 101 SITE 1 AC8 15 TRP B 180 ARG B 185 CYS B 186 VAL B 187 SITE 2 AC8 15 SER B 228 PHE B 355 SER B 356 TRP B 358 SITE 3 AC8 15 MET B 360 TRP B 449 PHE B 475 TYR B 477 SITE 4 AC8 15 H4B B 600 7F5 B 800 HOH B2060 SITE 1 AC9 11 TRP A 447 PHE A 462 GLU A 465 SER B 104 SITE 2 AC9 11 ARG B 367 ALA B 448 TRP B 449 HEM B 500 SITE 3 AC9 11 GOL B 880 HOH B2131 HOH B2154 SITE 1 BC1 9 TRP A 76 LEU B 107 GLN B 249 PRO B 336 SITE 2 BC1 9 VAL B 338 PHE B 355 HEM B 500 ACT B 861 SITE 3 BC1 9 GOL B 880 SITE 1 BC2 6 GLN B 191 TRP B 358 VAL B 420 SER B 428 SITE 2 BC2 6 HOH B2163 HOH B2164 SITE 1 BC3 7 GLN B 249 ARG B 252 TYR B 333 TYR B 359 SITE 2 BC3 7 ASN B 368 7F5 B 800 HOH B2100 SITE 1 BC4 8 TRP A 76 HOH A2214 VAL B 106 ARG B 367 SITE 2 BC4 8 HIS B 373 TRP B 449 H4B B 600 7F5 B 800 CRYST1 57.623 105.877 155.952 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017354 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009445 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006412 0.00000